title: Management of L-dopa overdose in the competitive inhibition state.
abstract: The amino acid L-3,4-dihydroxyphenylalanine (L-dopa) is prescribed for conditions where increased central and/or peripheral dopamine synthesis is desired. Its administration can establish dopamine concentrations higher than can be achieved from an optimal diet. Specific indications include Parkinson's disease and restless leg syndrome. The interaction between serotonin and dopamine exists in one of two distinctly different physiologic states: the endogenous state or the competitive inhibition state. Management with L-dopa in the competitive inhibition state is the focus of this paper. In the past, control of the competitive inhibition state was thought to be so difficult and complex that it was described in the literature as functionally "meaningless". When administering L-dopa without simultaneous administration of serotonin precursors, the patient is in the endogenous state. Experience gained with patient outcomes during endogenous L-dopa administration does not allow predictability of L-dopa outcomes in the competitive inhibition state. The endogenous approach typically increases the daily L-dopa dosing value in a linear fashion until symptoms of Parkinson's disease are under control. It is the novel observations made during treatment with the competitive inhibition state approach that L-dopa dosing values above or below the optimal therapeutic range are generally associated with the presence of the exact same Parkinson's disease symptoms with identical intensity. This recognition requires a novel approach to optimization of daily L-dopa dosing values from that used in the endogenous state. This paper outlines that novel approach through utilization of a pill stop. This approach enhances patient safety through its ability to prevent L-dopa overdose, while assisting in the establishment of the optimal therapeutic L-dopa daily dosing value.
authors.affiliation: Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, USA.
authors.forename: Marty
authors.initials: M
authors.lastname: Hinz
authors.affiliation: Stein Orthopedic Associates, Plantation, FL, USA.
authors.forename: Alvin
authors.initials: A
authors.lastname: Stein
authors.affiliation: Cole Center for Healing, Cincinnati, OH, USA.
authors.forename: Ted
authors.initials: T
authors.lastname: Cole
keywords: 4-dihydroxyphenylalanine; L-3; L-dopa; Parkinson’s disease; levodopa
references.citation: Neuropsychiatr Dis Treat. 2011 Jan 26;7:31-8
references.pmid: 21326653
references.citation: Int J Gen Med. 2012;5:413-30
references.pmid: 22615537
references.citation: Can Med Assoc J. 1962 Oct 13;87:802-7
references.pmid: 13966498
references.citation: Drug Healthc Patient Saf. 2011;3:69-77
references.pmid: 22171164
references.citation: Neuropsychiatr Dis Treat. 2011;7:457-63
references.pmid: 21857786
references.citation: Int J Gen Med. 2012;5:135-42
references.pmid: 22371656
references.citation: Int J Nephrol Renovasc Dis. 2011;4:101-13
references.pmid: 21912487
references.citation: Open Access J Urol. 2011 Feb 04;3:19-24
references.pmid: 24198631
references.citation: Int J Gen Med. 2011 Feb 28;4:165-74
references.pmid: 21475622
references.citation: Hypertension. 1997 Jan;29(1 Pt 2):228-34
references.pmid: 9039107
references.citation: Kidney Int. 1985 Jan;27(1):3-8
references.pmid: 3884879
references.citation: Hypertension. 2001 Sep;38(3):297-302
references.pmid: 11566894
references.citation: Postgrad Med J. 1975 Sep;51(599):619-21
references.pmid: 1105500
references.citation: Clin Exp Gastroenterol. 2010;3:171-7
references.pmid: 21694863
references.citation: Clin Sci (Lond). 1988 Nov;75(5):515-20
references.pmid: 3151165
references.citation: Am J Physiol. 1984 Sep;247(3 Pt 1):E285-90
references.pmid: 6433718
references.citation: J Lab Clin Med. 1995 Nov;126(5):470-3
references.pmid: 7595032
references.citation: Ren Physiol. 1985;8(3):150-8
references.pmid: 4023392
references.citation: Neuropsychiatr Dis Treat. 2010 Sep 07;6:387-92
references.pmid: 20856602
references.citation: Nihon Naibunpi Gakkai Zasshi. 1987 May 20;63(5):657-63
references.pmid: 3622859
references.citation: Am J Physiol. 1997 May;272(5 Pt 2):F632-9
references.pmid: 9176374